Kestra Medical Technologies, Ltd. Common Stock (KMTS) Stock
Key stats
- Market cap
- $1.88B
- Price / Earnings ratio
- -11.7x
- EPS (TTM)
- -$2.67
- Volume
- Loading
- 52-week high
- $31.91
- 52-week low
- $17.34
Source: third-party data provider, as of November 13, 2026
Compare with KMTS
Recent news
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
KMTS
Kestra Medical Technologies Q1 Earnings Call Highlights
Kestra Medical Technologies Q1 Earnings Call Highlights
KMTS
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
KMTS
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
KMTSNews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 61.07
- MACD 12/26/9
- 0.82
- EMA 9 of MACD
- 0.77
- MACD histogram
- 0.05
- SMA 50
- $27.26
- Price above SMA 50
- EMA 50
- $27.83
- Price above EMA 50
- SMA 200
- $24.04
- Price above SMA 200
- EMA 200
- $25.14
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2026Earnings
No data available
Source: third-party data provider
Latest news
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
KMTSKestra Medical Technologies Q1 Earnings Call Highlights
Kestra Medical Technologies Q1 Earnings Call Highlights
KMTSAnalysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
KMTSStrength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
KMTS
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
KMTS
Kestra Medical Technologies Q4 Earnings Call Highlights
Kestra Medical Technologies Q4 Earnings Call Highlights
KMTS
The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock
The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock
KMTSNews tone: automated (AI) classification of the article's content, not a price prediction.
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Brian Webster | Founder, President, CEO & Director | 1964 |
| Mr. Vaseem Mahboob | Chief Financial Officer | 1969 |
| Ms. Traci S. Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | 1963 |
| Mr. Gordon Teddy | Chief Information Officer | — |
| Mr. Alfred J. Ford Jr. | Chief Commercial Officer | 1971 |
| Mr. Neil Bhalodkar | Vice President of Investor Relations | — |
| Ms. Debra Schotz | Senior Vice President of Marketing | 1970 |
| Mr. Jeffrey Laub | Senior Vice President of Operations | 1971 |
| Mr. Timothy P. Moran | Chief Business Officer | 1972 |
| Mr. R. Curtis Kopf | Senior Vice President of Customer Experience | 1966 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 61.07
- MACD 12/26/9
- 0.82
- EMA 9 of MACD
- 0.77
- MACD histogram
- 0.05
- SMA 50
- $27.26
- Price above SMA 50
- EMA 50
- $27.83
- Price above EMA 50
- SMA 200
- $24.04
- Price above SMA 200
- EMA 200
- $25.14
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $32.00
- Average
- $33.00
- High
- $34.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.7 | +3.3 | -2.6 | +26.0 | -13.1 | +7.3 | +12.6 | +9.5 | +6.1 |
